Nurix Therapeutics, Inc. · NASDAQ:NRIX

Hansen Gwenn sold 1,452 Nurix Therapeutics, Inc. shares (Form 4)

Traded Oct 15, 2026 · Filed Oct 15, 2026

On Oct 15, 2026, Hansen Gwenn (Chief Scientific Officer) sold 1,452 Nurix Therapeutics, Inc. shares at US$25.00 for US$36,300 under a trading plan, leaving 117,227 shares. Filed Oct 15, 2026 (Form 4).

Sold: 1,452 shares
Price: US$25.00
Value: US$36,300
Holding after: 117,227 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Scientific Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 15, 2026	Common Stock	Option exercise	1,452	US$1.86	118,679	Direct
Oct 15, 2026	Common Stock	Sale	1,452	US$25.00	117,227	Direct

Source

Download original · View original at SEC

Related